tiprankstipranks
Akebia Therapeutics (AKBA)
NASDAQ:AKBA
US Market
AKBA
Akebia Therapeutics
RESEARCH TOOLSreports
Want to see AKBA full AI Analyst Report?

Akebia Therapeutics (AKBA) Income Statement

1,638 Followers

Akebia Therapeutics Income Statement

Last quarter (Q4 2025), Akebia Therapeutics's total revenue was $57.62M, an increase of 23.92% from the same quarter last year. In Q4, Akebia Therapeutics's net income was $-12.24M. See Akebia Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 236.20M$ 160.18M$ 194.62M$ 292.48M$ 211.65M
Gross Profit
$ 196.73M$ 97.00M$ 120.47M$ 269.99M$ 130.16M
Operating Expenses
$ 173.24M$ 147.47M$ 166.73M$ 350.77M$ 394.66M
Depreciation and Amortization
$ 1.27M$ 37.50M$ 37.63M$ 37.70M$ 37.97M
EBITDA
$ 21.73M$ -13.72M$ -8.27M$ 3.06M$ -189.91M
Operating Income
$ 23.50M$ -50.47M$ -46.26M$ -80.78M$ -264.50M
Other Income/Expenses
$ -27.22M$ -18.94M$ -5.67M$ -13.45M$ -17.52M
Pretax Income
$ -3.72M$ -69.41M$ -51.92M$ -94.23M$ -282.02M
Net Income
$ -5.34M$ -69.41M$ -51.92M$ -94.23M$ -282.02M
Per Share Metrics
Basic EPS
$ -0.02$ -0.33$ -0.28$ -0.58$ -1.48
Diluted EPS
$ -0.02$ -0.33$ -0.28$ -0.58$ -1.48
Weighted Average Shares Outstanding
 257.16M 210.95M 187.47M 182.78M 165.95M
Weighted Average Shares Outstanding (Diluted)
 257.16M 210.95M 187.47M 182.78M 165.95M
Currency in USD

Akebia Therapeutics Earnings and Revenue History